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Actinomycetes and filamentous fungi produce a wide range of bioactive compounds, with 
applications as antimicrobials, anticancer agents or agrochemicals. Their genomes contain a far larger 
number of gene clusters for natural products than originally anticipated, and novel approaches are 
required to exploit this potential reservoir of new drugs. Here, we show that co-cultivation of the 
filamentous model microbes Streptomyces coelicolor and Aspergillus niger has a major impact on 
their secondary metabolism. NMR-based metabolomics combined with multivariate data analysis 
revealed several compounds that correlated specifically to co-cultures, including the cyclic dipeptide 
cyclo(Phe-Phe) and 2-hydroxyphenylacetic acid, both of which were produced by A. niger in response 
to S. coelicolor. Furthermore, biotransformation studies with o-coumaric acid and caffeic acid resulted 
in the production of the novel compounds (E)-2-(3-hydroxyprop-1-en-1-yl)-phenol and (2E,4E)-3-(2-
carboxy-1-hydroxyethyl)-2,4-hexadienedioxic acid, respectively. This highlights the utility of microbial 
co-cultivation combined with NMR-based metabolomics as an efficient pipeline for the discovery of 
novel natural products.
Filamentous microorganisms have an enormous potential for the production of a wide range of bioac-
tive compounds, with application as among others antibiotic, anticancer or antifungal drugs1–3. In par-
ticular, the emergence of infectious diseases involving multi-drug resistant (MDR) bacterial pathogens 
since the 1980s has reinforced the screening efforts using filamentous microorganisms. It is likely that 
in terms of the biosynthetic potential of microbes we have only seen the tip of the iceberg4. However, 
the return of investment on high-throughput screening campaigns has dropped alarmingly, resulting in 
an almost complete withdrawal of BigPharma from the antibiotic scene5. Genome sequencing has now 
revealed that prolific antibiotic producers, and in particular fungi6–8 and actinomycetes9–11, which had 
been intensively studied for decades, harbour far more biosynthetic gene clusters for natural products 
than originally anticipated. The challenge scientists now face is to elicit the expression of these potential 
treasures, via chemical, genetic or biological triggers12,13. Strategies that have been employed include het-
erologous expression14, screening or selecting for antibiotic resistant strains15,16, and the use of chemical 
elicitors17,18. Besides the activation of cryptic gene clusters in known species, a second major reservoir 
for natural products is formed by microorganisms that have not yet been cultivated, which recently led 
to the discovery of novel antibiotics in unexpected microbial sources19,20.
Growth in microbial communities or interactions between different microorganisms is the next log-
ical step in the search for new molecules, as many natural products can be expected to be activated 
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specifically by competitors or symbionts in the natural habitat. Microbial co-cultures have been shown 
to elicit the biosynthesis of novel metabolites, thus increasing the pre-existent chemical diversity21,22. 
The model microorganisms that are studied intensively in our laboratory are Streptomyces coelicolor, a 
Gram-positive bacterium with a complex multicellular lifestyle23, and the fungus Aspergillus niger. It was 
shown previously that interaction with bacteria may have profound effects on the producing ability of 
Aspergillus species24,25. Here, we report the application of co-cultivation of S. coelicolor and A. niger for 
the discovery of novel natural products. In addition, the structurally related o-coumaric acid and caf-
feic acid were specifically converted into the novel molecules (E)-2-(3-hydroxyprop-1-en-1-yl)-phenol 
and (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-2,4-hexadienedioxic acid, respectively. We thereby apply 
NMR-based metabolomics, a technology that is particularly effective in identifying molecules in com-
plex biological mixtures, which therefore facilitates the direct biochemical analysis of the community 
metabolism26. While routinely applied in plant metabolomics, its application in microbial research is 
rare27.The combination of microbial co-cultivation with NMR-based metabolomics is presented as an 
efficient way to discover new molecules.
Results and discussion
The interaction between the two filamentous model microbes Streptomyces coelicolor A3(2) M145 and 
Aspergillus niger N402 was studied in co-cultivations in submerged NMMP cultures. Preliminary exper-
iments indicated that the pH of the medium had contrasting effects on the growth of both microbes: 
whereas Streptomyces species grow well at neutral pH, those of Aspergillus grow optimally at lower pH 
values. A phosphate buffer of pH 5 was optimal for obtaining sufficient biomass of both microorganisms 
for a mutual interaction to occur. As the growth rate of A. niger was higher under these conditions, the 
fungal spores were added to the culture flasks 72 h after inoculation of S. coelicolor. To allow the ready 
visualization of the interaction between the two microorganisms, we used a test setup with A. niger 
AR19#1 which expresses eGFP28. A. niger AR19#1 formed pellets with a diameter of 100-500 μ m that 
were rapidly colonized by S. coelicolor within 24 h after addition of A. niger to the Streptomyces culture. 
The colonization initiated with the adhesion of S. coelicolor to the A. niger biomass (Fig.  1A,D), even-
tually leading to pellets that were largely covered with Streptomyces biomass after 72 h of co-cultivation 
(Fig. 1B,E). Notably, loose fungal hyphae were evident in the culture broth in the following 24 h, inferring 
that the fungal mycelium was almost completely degraded by the bacterium (Fig. 1C,F).
Figure 1. Mycelial interactions between Aspergillus niger AR19#1 (large open mycelial structures) and 
Streptomyces coelicolor A3(2) M145 (small red-pigmented pellets indicated by arrow heads) during 
co-culture. Strain AR19#1 is a derivative of A. niger N402 which expresses eGFP. Samples were observed 
following inoculation of A. niger at 24 h (A,D), 72 h (B,E), and 96 h (C,F). The reduction in fluorescence 
intensity in the eGFP-positive hyphae of A. niger (D-F) highlights the strong decline in viable fungal 
biomass in later stages of the co-culture. Bar, 250 μ m (A,B) or 125 μ m (C).
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Previous studies have shown that evident metabolic changes occur when different organisms are 
grown together29. An NMR-based metabolomics approach was employed to study such effects in 
the Aspergillus-Streptomyces co-cultivations, using S. coelicolor A3(2) M145 and A. niger N402 (the 
plasmid-free parent of strain AR19#1, i.e. not expressing eGFP). The method of NMR-based metab-
olomics was performed according to our previously published protocol, including sample preparation, 
NMR analysis, metabolite identification and multivariate data analysis26. In the current study, a total of 
30 liquid cultures (10 for each monoculture and 10 for the coculture) were separately extracted followed 
by global NMR-profiling of the secondary metabolites (Figure S1). The 1H NMR spectra were then sub-
jected to statistical analysis. An unsupervised principal component analysis (PCA) revealed clustering 
of the samples in three groups, indicating that the co-culture fingerprints did not overlap with the two 
corresponding monoculture clusters (Fig.  2). This showed that the dataset contained information that 
allowed the discrimination of the chemical composition of the co-culture from that of the monocultures. 
Features exclusively related to the co-culture were found within the dataset of induced compounds (see 
below), implying that microbial interactions modulated the biosynthetic pathways for the production of 
secondary metabolites. The PCA loading plot (not shown) allowed detecting biomarkers responsible for 
the discrimination among the three groups. The compounds were identified with different NMR tech-
niques (1D and/or 2D experiments) and UHPLC-TOF-MS analysis (positive and/or negative modes) 
(Table  1) and the results were compared with spectroscopic data from literature. The major discrimi-
nators for the S. coelicolor culture were the well-studied pigmented antibiotics undecylprodigiosin and 
actinorhodin30,31, while the A. niger monoculture was abundant in the γ -pyrone derivative carbonarone 
A32, as well as several minor components, namely naphtho-γ -pyrone aurasperone B, and fumonisins 
B2 and B433,34. Notably, some compounds accounting for the PCA separation of the metabolites in the 
co-culture were identified as the previously described compounds cyclo-(Phe-Phe)35, cyclo-(Phe-Tyr)36, 
phenylacetic acid37, 2-hydroxyphenylacetic acid37, and furan-2-carboxylic acid38 (Fig. 3).
Recently, the implementation of the co-cultivation strategy attracted considerable interest and appli-
cation, since it proved to be an effective way to harvest unique structures with pronounced biologi-
cal activities29. It may trigger biosynthetic pathways for ‘cryptic’ natural products that would otherwise 
remain silent under standard laboratory culture conditions. However, often it has not been established 
which of the co-cultivated microorganisms is actually responsible for manufacturing these metabolites. 
Here, we focused on the production of cyclo(Phe-Phe) that was produced abundantly in the co-culture 
of A. niger with S. coelicolor. Since Aspergilli produce 2,5-diketopiperazine-type compounds29,39, A. niger 
was the most obvious candidate. To test this hypothesis, A. niger was inoculated into the culture filtrate 
(supernatant without bacterial biomass) of a 5-day-old S. coelicolor culture and incubated for another 
two days. 1H NMR metabolic profiling (Figure S2) unambiguously demonstrated that the culture filtrate 
of S. coelicolor effectively elicited the production of cyclo(Phe-Phe) and phenylacetic acid by A. niger. 
We hypothesize that A. niger metabolizes phenylalanine into phenylacetic acid, which is then further 
oxidized to 2-hydroxyphenylacetic acid40, while cyclo(Phe-Phe) can be synthesized by condensation and 
cyclization of two molecules of phenylalanine41,42.
Figure 2. Unsupervised (PCA) multivariate data analysis of the 1H NMR fingerprint data included in 
Figure S1. Circles represent the S. coelicolor monoculture, squares the A. niger monoculture, while the co-
culture of S. coelicolor and A. niger is represented by triangles.
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Thus, compounds in the culture fluid derived from S. coelicolor allowed the production of secondary 
metabolites by A. niger, without the need for physical interaction between them. In contrast, direct con-
tact was required for the biosynthesis of the aromatic polyketides orsellinic acid, lecanoric acid, F-9775A 
and F-9775B in a co-culture of Aspergillus nidulans and Streptomyces hygroscopicus43. We then investi-
gated whether exogenously added compounds could also act as starter material for bioconversion to new 
compounds. For this, co-cultivation was done in the presence of one of a variety of hydroxycinnamic 
acids. Seven structurally related molecules, namely cinnamic acid, o-, m- and p- coumaric acid, caffeic 
acid, ferulic acid, and sinapinic acid, were fed as substrates to the co-culture and to each of the monocul-
tures. After incubation, the cultures were extracted with ethyl acetate and subsequently subjected to 1H 
NMR and UHPLC-TOF-MS analysis (positive and/or negative modes) without further chromatographic 
fractionation. All of the compounds obtained by bioconversion by the three types of cultures were unam-
biguously identified on the basis of spectral data (Table S1-S7) and summarized (Figure S3-S9). All 
structures could be readily elucidated based on spectra of known compounds, except for the novel com-
pound 1 (see below). Under these culturing conditions, the majority of substrates were almost completely 
consumed by A. niger, whereas S. coelicolor exhibited a limited capacity to convert these substrates, 
yielding at best trace amounts of biotransformation products. However, although the biotransformation 
process in co-cultures was dominated by A. niger, both qualitative and quantitative differences were 
found between the mono- and co-cultures in terms of the biotransformation compounds. The addition 
of o-coumaric acid to the co-culture yielded (E)-2-(3-hydroxyprop-1-en-1-yl)-phenol, which was not 
produced in either of the two monocultures (Fig. 4).
Unexpectedly, caffeic acid was converted by A. niger in both mono- and co-culture into a previously 
undescribed compound (1). Its molecular formula, C9H10O7, was determined using UHPLC-TOF-2Q 
high-resolution mass analysis with an ion at m/z 211.0254 [M – H2O – H]– (calculated mass for C9H8O6 
is 211.0254). The 1H NMR spectrum exhibited a characteristic signal corresponding to a trans-substituted 
Producer Compounds
Molecular 
Formula
Characteristic 1H NMR 
Chemical shifts
Exact 
Mass
Experimental high 
resolution mass Reference
S. coelicolor Undecylprodigiosin C25H35N3O
7.32 (dd, J = 2.4, 1.2); 
6.37 (dd, J = 4.2, 1.2); 
6.18 (d, J = 4.2); 2.78 (m)
393.2780 394.2854 [M + H]+
31
Actinorhodin C32H26O14 7.38 (s) 634.1323
657.3169 [M + 
Na]+; 633.1256 
[M – H]–
30
A. niger Carbonarones A C13H11NO3
8.88 (s); 7.24 (d, J = 8.4); 
7.37 (m); 7.31 (m); 6.38 
(s); 3.88 (s)
229.0739
230.0809 [M + 
H]+; 252.0630 [M 
+ Na]+; 269.1353 
[M + K]+;
32
Fumonisin B2 C34H59NO14 705.3936
706.4009 [M + 
H]+
34
Fumonisin B4 C34H59NO13 689.3986
690.4063 [M + 
H]+; 688.3917 [M 
– H]–
33
Aurasperone B C32H30O12
6.64 (d, J = 2.4); 3.93 (s); 
3.72 (s); 3.60 (s); 3.13 
(d, J = 17.4); 3.12 (d, 
J = 17.4)
606.1737
607.1808 [M + 
H]+; 629.1605 [M 
+ Na]+; 605.1665 
[M – H]–
33
Co-culture Cyclo-(Phe-Phe) C18H18N2O2
7.33 (t, J = 7.8); 7.25 (m); 
7.10 (brd, J = 7.8); 4.08 
(dd, J = 7.2, 4.2); 2.78 
(dd, J = 13.2, 4.2); 2.14 
(dd, J = 13.2, 7.2)
294.1368
295.1429 [M + 
H]+; 317.1238 [M 
+ Na]+
35
Cyclo-(Phe-Tyr) C18H18N2O3
7.33 (t, J = 7.8); 7.25 
(m); 7.10 (brd, J = 7.8); 
6.88 (d, J = 8.4); 6.68 (d, 
J = 8.4)
310.1317
311.1379 [M + 
H]+; 333.1185 [M 
+ Na]+
35
Phenylacetic acid C8H8O2
3.58 (s); 6.77 (m); 7.09 
(m) 136.0524
135.0442 [M 
− H]–
37
2-hydroxyphenylacetic C8H8O3 3.47 (s) 152.0473
153.0551 [M + 
H]+
40
Furan-2-carboxylic acid C5H4O3
7.61 (dd, J = 1.8, 1.2); 
7.06 (dd, J = 3.6, 0.6); 
6.51 (dd, J = 3.6, 1.8)
112.0160
135.0413 [M + 
Na]+; 111.0090 [M 
− H]–
38
Table 1.  Spectral data assignments for the compounds displayed in Fig. 3. All compounds were 
summarized according to their corresponding producers, namely S. coelicolor monoculture, A. niger 
monoculture, and referred co-culture. Compound identification was based on 1H NMR and/or high 
resolution mass spectrometry, and compared with literature. Proton coupling constants (J in Hz) are given in 
parentheses.
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Figure 3. Major discriminating compounds responsible for the PCA separation (Fig. 2) of the S. 
coelicolor and A. niger monocultures from their co-culture. S. coelicolor monoculture: undecylprodigiosin 
and actinorhodin; A. niger monoculture: carbonarones A, aurasperone B, fumonisin B2 and fumonisin 
B4; Co-culture: cyclo(Phe-Phe), cyclo(Phe-Tyr), phenylacetic acid, 2-hydroxyphenylacetic acid, and furan-
2-carboxylic acid. The shown theoretical exact mass of each compound was calculated with ChemDraw 
Ultra 12.0 software. The structure elucidation was done on the basis of NMR and/or experimental UHPLC-
TOF-MS high resolution mass, and the spectral data assignments were summarized in Table 1.
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olefinic bond, δH 6.42 (d, J = 16.2 Hz), 7.47 (dt, J = 16.2, 0.6 Hz), which indicated the acrylic acid side 
chain of caffeic acid resisted the biodegradation. The disappearance of the typical ABX system proton 
signals for 1,2,4-trisubstituted benzene moiety implied that this aromatic ring had been opened. With the 
aid of 2D NMR experiments (1H-1H COSY, HSQC, HMBC, Figure S10-S14), the planar structure of com-
pound 1 was unambiguously identified as (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-2,4-hexadienedioxic 
acid (Table 2) shown in Fig. 1. The formation of 1 was likely due to oxygenation of caffeic acid resulting 
in cleavage of the aromatic ring between two adjacent hydroxyl groups, thus producing two carboxyl 
groups at the site of ring opening44. We propose that the resulting product 4-carboxymethylene-2,5
-heptadienoic acid44 reacts with one molecule of water to generate the final adduct (2E,4E)-3-(2-carboxy-
1-hydroxyethyl)-2,4-hexadienedioxic acid (Figure S7). In view of the oxidative cleavage of the benzene 
ring, the geometry at theΔ 2,3 double bond was established as E. Because the nucleophilic addition of 
olefin with H2O tends to generate racemates, the stereochemistry at C-1’ was assigned to be both R and S. 
The (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-2,4-hexadienedioxic acid bioconversion rate was accelerated 
Figure 4. Biotransformation products of o-coumaric acid and caffeic acid by S. coelicolor and A. niger 
monocultures and their co-culture. The boxed compound (E)-2-(3-hydroxyprop-1-en-1-yl)-phenol was 
exclusively detected in co-culture. The structurally novel molecule (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-2,4-
hexadienedioxic acid was derived from caffeic acid biotransformation by fungus, while conversion rate was 
around 3.5 times in co-culture
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when A. niger was co-cultivated with S. coelicolor, to around 3.5 times the rate of that occurring in the 
fungal monoculture.
In conclusion, co-cultivation of S. coelicolor and A. niger allowed the production of the compounds 
cyclo(Phe-Phe), 2-hydroxyacetic acid and phenylacetic acid by A. niger that were not produced by its 
monoculture. The fact that the bacterial cell-free filtrate was sufficient for cyclo(Phe-Phe) and phenylac-
etic acid production by A. niger proves that the change in fungal phenylalanine metabolism was induced 
by secreted compounds that act as starter molecules or as elicitors of silent biosynthetic pathways, rather 
than by cell-to-cell contact with or nutrient depletion by S. coelicolor. NMR-based metabolomics cou-
pled to eliciting compounds by microbial co-cultivation is thereby a very effective strategy to derepli-
cate known molecules and effectively highlighted the compounds induced specifically by co-cultivation. 
In addition, chemical modification of hydroxycinnamic acids was achieved by Aspergillus and/or 
Streptomyces biotransformation, whereby only the co-culture specifically converted o-coumaric acid into 
(E)-2-(3-hydroxyprop-1-en-1-yl)-phenol. Importantly, besides novel metabolic activity, the biotrans-
formation also allowed the discovery of the novel compound (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-
2,4-hexadienedioxic acid, which was produced following addition of caffeic acid. Thus, implementation 
of co-cultivation and biotransformation has the capacity to increase chemical diversity, which offers new 
leads for drug-discovery efforts.
Methods
Bacterial strains and culturing conditions. Streptomyces coelicolor A3(2) M14545 was obtained 
from the John Innes Centre strain collection, Aspergillus niger N402 (cspA1) is a derivative of A. niger 
ATCC9029. A. niger AR19#128 expresses eGFP under control of the A. nidulans gpdA promoter. NMMP45 
was used as liquid minimal media for all co-cultivation experiments. Growth curves of S. coelicolor M145 
were set up in 50 ml NMMP with glucose (0.5% w/v) as described46, with an inoculum of 106 spores in 
250 ml flasks equipped with a spring, and grown at 30 °C with constant shaking at 160 rpm. After 72 h, 105 
spores of A. niger N402 were added to the culture, and cultivation continued for another 72 h. In parallel, 
monocultures of S. coelicolor and A. niger were grown for 144 h and 72 h, respectively, corresponding to 
the cultivation time of each strain in the co-culture. Ten replicates of each experiment, namely Aspergillus 
niger monoculture, Streptomyces coelicolor monoculture, and the coculture (so 30 samples in total), were 
prepared for the metabolomics studies. Fluorescence and corresponding light micrographs were obtained 
with a Zeiss Axioscope A1 upright fluorescence microscope (with an Axiocam Mrc5 camera at a resolu-
tion of 37.5 nm/pixel) as described47. The green fluorescent images were created using 470/40 nm band 
pass (bp) excitation and 525/50 bp detection.
Biotransformation of hydroxycinnamic acids. Seven hydroxycinnamic acid congeners (cinnamic 
acid, o-coumaric acid, m-coumaric acid, p-coumaric acid, caffeic acid, ferulic acid, and sinapinic acid) 
NO. δC
δH (J in 
Hz)
HMBC 
(1H→13C) COSY (1H→1H)
1 172.4
2 120.6 6.42 (d, J = 0.6) C-1, C-4, C-1' H-1'
3 162.5
4 132.0
7.47 (dt, 
J = 16.2, 
0.6)
C-1’, C-2, C-6, 
C-5, C-3 H-5, H-1'
5 128.5 6.42 (d, J = 16.2) C-6, C-3, C-4 H-4
6 167.1
1' 79.0
5.68 
(dddd, 
J = 7.2, 3.6, 
1.8, 0.6)
H-2, H-4, H-2'
2' 37.6
3.07 (dd, 
J = 16.8, 
3.6); 
2.58 (dd, 
J = 16.8, 
3.6)
C-3’, C-3 H-1'
3' 171.1
Table 2. 1H and 13C NMR data assignment for new compound (2E,4E)-3-(2-carboxy-1-hydroxyethyl)-2,4-
hexadienedioxic acid (1) in CD3OD. Proton coupling constants (J in Hz) are given in parentheses. 1H NMR 
and 13C NMR spectra were recorded at 600 MHz. All chemical shift assignments were done on the basis of 
1D- and 2D -NMR techniques.
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were selected as substrates for the biotransformation study. For this, 10 mg of each substrate dissolved in 
200 μ l DMSO were added to the co-culture, 24 h after addition of A. niger to the S. coelicolor culture. In 
parallel, the substrates were added to monocultures of S. coelicolor (after 96 h) and A. niger (after 24 h), 
corresponding to the cultivation time of each strain in the co-culture. The biotransformation products 
were analyzed 48 h after adding the substrates. All biotransformation experiments were conducted in 
triplicate.
Extraction of metabolites. Culture replicates were harvested by centrifugation at 4000 rpm for 
10 min. The culture broth (50 ml) was extracted twice with 20 ml of ethyl acetate. The organic phase was 
washed with 30 ml of water and subsequently dried with 5 g of anhydrous Na2SO4. Finally, the EtOAc 
was removed under vacuum at 38 °C and the residue was dissolved in 2.0 ml of EtOAc in a microtube 
(Eppendorf type-5415C, Hamburg, Germany). The solvent was then evaporated at room temperature 
under nitrogen gas, and subsequently dipped into liquid nitrogen and lyophilized using a freeze dryer 
(Edwards Ltd., Crawley, England).
NMR measurements. NMR sample preparation and measurements were performed according to 
a protocol that was published previously26. Briefly, 500 μ l of methanol-d4 were added to freeze-dried 
samples, and the resultant mixtures were vortexed for 10 sec and sonicated for 20 min at 42 kHz using 
an Ultrasonicator 5510E-MT (Branson, Danbury, CT, USA), followed by centrifugation at 16,000x g at 
room temperature for 5 min. The supernatant (300 μ l) was transferred to a 3 mm micro NMR tube and 
analyzed. The 1H NMR spectra were recorded at 25 °C on a 600 MHz Bruker DMX-600 spectrometer 
(Bruker, Karlsruhe, Germany) operating at a proton NMR frequency of 600.13 MHz. Deuterated meth-
anol was used as the internal lock. Each 1H NMR spectrum consisted of 128 scans using the following 
parameters: 0.16 Hz/point, pulse width (PW) = 30 (11.3 ls) and relaxation delay (RD) = 1.5 s. Free induc-
tion decays (FIDs) were Fourier transformed with a line broadening (LB) = 0.3 Hz. The resulting spectra 
were manually phased and baseline corrected, and calibrated to methanol at 3.30 ppm, using XWIN 
NMR (version 3.5, Bruker).
UHPLC-TOF mass spectrometry. The UHPLC-TOF-MS analyses were performed on an Ultimate 
3000 UHPLC system (Thermoscientific, USA) coupled to a micro-ToF-2Q mass spectrometer from 
Bruker Daltonics (Bremen, Germany) with an electrospray (ESI) interface48. In separate runs, detection 
was achieved in both positive and negative ion modes. The m/z range was set to be 100–1000 and the 
ESI conditions were as follows: capillary voltage of 3500 V, source temperature of 250 °C, desolvation 
temperature of 250 °C, dry gas low of 10.0 l/min and the nebulizer at 2.0 Bar. For positive ionization, all 
conditions were the same and the capillary voltage was 4000 V. Internal calibration was performed using 
a 10 mM sodium formate solution from Sigma–Aldrich (Steinheim, Germany). Samples of 3 μ l were 
injected onto a Kinetex C18, 150 × 2.0 mm column, packed with 1.7 μ m particles (Phenomenex, USA), 
and eluted in gradient mode at a flow rate of 0.3 ml/min with the following solvent system: (A) 0.1% 
formic acid (v/v) in water; (B) 0.1% (v/v) formic acid in acetonitrile. Analysis began with a gradient of 
5% to 90% B to in 19.5 min, followed by an isocratic step of 90% B for 1 min and a re-equilibration of 
1 minute with 5% B. The total run time was 21.5 min. The temperature was maintained at 30 °C.
Multivariate Data analysis. The 1H NMR data files were processed as described26,49. The 1H NMR 
spectra were converted to an ASCII file using AMIX software (Bruker Biospin GmbH), with total inten-
sity scaling. Bucketing or binning was performed and the spectral data were reduced to include regions of 
equal width (0.04 ppm) equivalent to the region of δ 0.30–10.02. The regions of δ 4.85 – 4.95 and δ 3.25 
– 3.35 were removed in the analysis because of the remnant signals of the solvents, HDO and CD3OD, 
respectively. Principal component analysis (PCA) was performed with the SIMCA-P+ software (Version 
13.0, Umetrics, Umeå, Sweden). Pareto-scaling method was used for PCA.
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